Hand Eczema (HE) Treatment Market by registering a CAGR of 8% from 2023 to 2033

The global Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023 and is expected to accumulate a market value of US$ 114.42 Million by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Hand Eczema (HE) Treatment registered a CAGR of 4% in the historical period 2018 to 2022. According …

Biodefense Market is projected to reach a revised size of US$ 32.99 billion by 2033 | FMI

It is estimated that the market is anticipated to reach US$ 32.99 billion by 2033 after being valued at US$ 16.31 billion in 2023. This market is projected to expand at a CAGR of 7.3% during the analysis period. The growing demand for vaccines, drugs, and medical devices provides companies with opportunities to expand their …

Intratumoral Cancer Therapies Market value of US$ 552.36 Billion by registering a CAGR of 10% from 2023 to 2033

A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be attributed to favorable regulatory frameworks for cancer …

Disposable Cutlery Market to US$ 2.6 billion by 2033 With CAGR 4.9% – Get Insight Story

As per the recent market research conducted by FMI, the global disposable utensils market is expected to value US$ 2.6 billion by 2033. In 2023, the market size is anticipated to be US$ 1.6 billion. The CAGR during the forecast period is projected to be at 4.9%. The COVID-19 pandemic has taught the world to …

IgA Nephropathy Market value of US$ 85 Billion by registering a CAGR of 7.5% from 2023 to 2033

During the forecast period 2023 to 2033, the IgA nephropathy market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of …

Combined Sales of Anti-biofilm Wound Dressing is expected to reach US$ 1939.45 million by 2033

The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofilm wound dressings. Besides antimicrobial resistance and …

Head and Neck Cancer (HNC) Therapeutics market is forecast to reach US$ 5.19 Billion by 2033, growing at a CAGR of 12.6% until 2033

The global Head and Neck Cancer (HNC) Therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion as they are less …

Filariasis Treatment Market to reach US$ 28.68 Billion by 2033, Drugs to account for Bulk of all Treatments | FMI Study

According to Future Market Insights, global filariasis treatment is expected to grow at a CAGR of 10.1% between 2023 and 2033, reaching US$ 28.68 billion in 2033. The increasing prevalence of filariasis and improved diagnostic capabilities are expected to drive growth in the filariasis treatment market. The availability of effective treatments and awareness of the disease is …

Oral Route of Administration Expected to Hold 53% Of Market Share for Birch Allergy Treatment Market | FMI Study

During the forecast period 2023 to 2033, the Birch allergy treatment market is expected to grow at a value of 7% CAGR, according to Future Market Insights. By the year 2033, the global market for Birch allergy treatment is expected to rise up to a market valuation of US$ 1123.24 Million. Growth of the market can be …

Glaucoma Therapeutics Market is expected to grow at a 3.7% CAGR from Forecast 2022 to 2032

The market study depicts an extensive analysis of all the players running in the Glaucoma Therapeutics Market The market for glaucoma treatments is anticipated to reach US$ 6.9 million in 2022. Between 2022 and 2032, the worldwide demand for glaucoma therapies is predicted to increase at a CAGR of 3.7%, reaching over US$ 10.2 million by …